Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Thermogenesis Holdings stock

THMO
US88362L1008
A2PUSP

Price

0.00
Today +/-
+0.00
Today %
+15.38 %

Thermogenesis Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Thermogenesis Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Thermogenesis Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Thermogenesis Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Thermogenesis Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Thermogenesis Holdings Stock Price History

DateThermogenesis Holdings Price
12/18/20240.00 undefined
12/17/20240.00 undefined
12/16/20240.00 undefined
12/13/20240.00 undefined
12/12/20240.00 undefined
12/11/20240.00 undefined
12/10/20240.00 undefined
12/9/20240.00 undefined
12/6/20240.00 undefined
12/5/20240.00 undefined
12/3/20240.00 undefined
12/2/20240.00 undefined
11/29/20240.00 undefined
11/27/20240.00 undefined
11/26/20240.00 undefined
11/25/20240.00 undefined
11/22/20240.00 undefined
11/21/20240.00 undefined

Thermogenesis Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Thermogenesis Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Thermogenesis Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Thermogenesis Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Thermogenesis Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Thermogenesis Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Thermogenesis Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Thermogenesis Holdings’s growth potential.

Thermogenesis Holdings Revenue, EBIT and net profit per share

DateThermogenesis Holdings RevenueThermogenesis Holdings EBITThermogenesis Holdings Net Income
2029e30.25 M undefined0 undefined8.25 M undefined
2028e29.97 M undefined13.11 M undefined8.25 M undefined
2027e25.62 M undefined9.16 M undefined5.66 M undefined
2026e25.1 M undefined8.14 M undefined5.01 M undefined
2025e21.53 M undefined5.2 M undefined3.23 M undefined
2024e17.24 M undefined2.07 M undefined1.29 M undefined
20239.45 M undefined-6.57 M undefined-17.98 M undefined
202210.48 M undefined-6.19 M undefined-11.27 M undefined
20219.29 M undefined-7.23 M undefined-11.38 M undefined
20209.74 M undefined-8.9 M undefined-16.35 M undefined
201913.05 M undefined-4.73 M undefined-9.5 M undefined
20189.67 M undefined-10.47 M undefined-39.72 M undefined
201714.53 M undefined-9.24 M undefined-29.1 M undefined
201611.93 M undefined-10.86 M undefined-18.59 M undefined
201516.04 M undefined-14.86 M undefined-14.85 M undefined
201415.99 M undefined-9.04 M undefined-8.63 M undefined
201317.96 M undefined-5.07 M undefined-3.09 M undefined
201219.02 M undefined-5.38 M undefined-4.99 M undefined
201123.4 M undefined-2.84 M undefined-2.57 M undefined
201023.09 M undefined-5.25 M undefined-5.19 M undefined
200919.8 M undefined-8.78 M undefined-8.55 M undefined
200821.95 M undefined-10.37 M undefined-9.18 M undefined
200716.75 M undefined-8.54 M undefined-6.78 M undefined
200612.05 M undefined-6.97 M undefined-6.14 M undefined
200510.18 M undefined-8.42 M undefined-8.22 M undefined
200411.65 M undefined-4.84 M undefined-4.78 M undefined

Thermogenesis Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0001111223464545910111012162119232319171516111491399109172125252930
-------100.00-50.0033.3350.00-33.3325.00-20.0025.0080.0011.1110.00-9.0920.0033.3331.25-9.5221.05--17.39-10.53-11.766.67-31.2527.27-35.7144.44-30.77-11.11-10.0088.8923.5319.05-16.003.45
---100.00100.00100.00100.0050.0050.0033.3350.0033.33-25.0020.0025.0020.0011.1120.0027.2730.0033.3331.2528.5726.3230.4334.7831.5835.2933.3325.0018.1835.7122.2238.4611.1133.3320.0011.115.884.764.004.003.453.33
000000001122-10001233456578665425251321000000
00-1000-10000-4-9-10-6-6-5-5-4-8-6-6-9-8-5-2-4-3-8-14-18-29-39-9-16-11-11-17135588
------------125.0011.11-40.00--16.67--20.00100.00-25.00-50.00-11.11-37.50-60.00100.00-25.00166.6775.0028.5761.1134.48-76.9277.78-31.25-54.55-105.88200.0066.67-60.00-
0000000000000000000000000000000.010.020.040.060.140.260.552.37000000
--------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Thermogenesis Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Thermogenesis Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                                       
0.060.510.20.360.270.380.361.243.511.982.332.555.376.736.8216.619.573933.3825.2915.6310.7312.317.886.8814.813.365.843.623.512.43.167.167.284.182
0.310.520.560.450.530.890.681.442.071.281.20.631.371.922.013.112.923.773.235.984.246.13.964.564.94.695.133.173.72.551.511.281.380.731.870.95
000000000000000000000000000000000000
0.170.350.320.380.630.551.012.142.582.462.722.281.842.892.652.473.282.795.055.135.235.036.356.294.265.614.63.593.624.84.493.825.885.373.331.41
0.030.180.010.130.120.040.010.040.250.180.220.150.10.120.820.580.470.460.420.370.660.30.420.340.230.220.160.250.240.590.221.60.881.581.510.83
0.571.561.091.321.551.862.064.868.415.96.475.618.6811.6612.322.7716.2446.0242.0836.7725.7622.1623.0419.0716.2725.3313.2512.8511.1811.458.629.8615.314.9610.895.18
0.060.060.080.20.170.140.220.711.361.681.461.080.810.540.441.151.181.491.61.451.781.71.311.652.212.32.942.962.3332.562.892.151.835.185.8
000807050900000000000000000000000001010000
000000000000000000000000000000000000
0.440.340.730.580.420.330.280.220.170.1100000000000000.32021.9321.320.8220.1721.631.591.471.361.321.290
000000000000000000000000013.2513.213.213.213.980.780.780.780.780.780
00000.080.110.020.140.260.120.210.050.070.060.050.20.050.090.120.070.110.170.050.050.050.080.080.080.061.061.050.211.261.761.260.26
0.50.40.810.860.740.630.611.071.791.911.671.130.880.60.491.351.231.581.721.521.891.871.362.022.2637.5637.5237.0635.7639.675.985.365.565.698.516.05
1.071.961.92.182.292.492.675.9310.27.818.146.749.5612.2612.7924.1217.4747.643.838.2927.6524.0324.421.0918.5362.8950.7749.9146.9451.1214.615.2220.8620.6519.411.23
                                                                       
10102020202020102020203030404050506060601010202020404001010200101004
3.093.885.387.077.687.787.810.7519.226.2937.4443.0151.9759.2765.2580.4181.75115.77118.38120.28120.8121.32126.2126.99127.49171.42172.54188.57216.22221.37235.87237.31259.06268.45270.38282.38
-2.54-3.35-4.02-5.48-5.74-5.73-5.81-6.38-11.19-20.74-30.74-37.34-44.07-49.11-54.71-59.49-67.71-73.85-80.63-89.81-98.36-103.55-106.12-111.11-114.19-122.82-137.67-156.26-185.36-187.64-227.44-236.93-253.28-264.66-266.19-284.17
0000000000000000-600000000060-10-40-40-40-1002030110114
000000000000000000000000000000000000
0.560.541.381.611.962.072.014.388.035.576.725.77.9310.210.5820.9714.0341.9837.8130.5322.4517.7820.115.913.3248.734.932.2730.8333.78.440.385.813.834.3-1.67
0.320.210.270.470.260.310.510.931.441.30.640.510.7711.171.711.791.932.074.191.782.381.792.773.113.595.082.651.62.082.421.451.371.280.820.95
0.080.10.110.10.070.120.140.190.320.760.720.380.470.440.6110.740.841.471.82.212.111.521.840.480.60.710.450.390.532.222.162.432.792.321.74
00000000.040.09000.060.330.570.150.240.610.920.760.80.851.080.750.421.572.192.162.452.532.851.733.081.91.471.631.42
0.11.10000000000000000000000000000000000
0.0100.0500000.120.150.160.030.040.010.010.020.020.010000000000000000.450.816.747.66
0.511.410.430.570.330.430.651.2822.221.390.991.582.021.952.973.153.694.36.794.845.574.065.035.166.387.955.554.525.466.376.696.156.3511.5111.76
000.100000.280.1600.030.050.050.030.040.020.050.030.02000000002.493.56.71.174.936.639.2500
00000000000000000000000007.647.647.646.974.73000000
0000000.0100000000.240.150.241.921.650.970.360.680.240.150.060.170.271.951.111.010.342.682.221.664.553.05
000.10000.010.280.1600.030.050.050.030.280.170.291.951.670.970.360.680.240.150.067.817.9112.0811.5812.441.517.618.8510.914.553.05
0.511.410.530.570.330.430.661.562.162.221.421.041.632.052.233.143.445.645.977.765.26.254.35.185.2214.1915.8617.6316.117.97.8814.31517.2616.0614.82
1.071.951.912.182.292.52.675.9410.197.798.146.749.5612.2512.8124.1117.4747.6243.7838.2927.6524.0324.421.0818.5462.8950.7649.946.9351.616.3214.6820.8121.0920.3613.15
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Thermogenesis Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Thermogenesis Holdings's financial health and stability.

Assets

Thermogenesis Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Thermogenesis Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Thermogenesis Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Thermogenesis Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201720182019202020212022
-1-1000-10000-4-9-6-5-6-5-5-4-8-6-6-9-8-5-2-4-3-8-14-18-29-2-40-10-16-11-11
00000000000000000000000000001,0001,0000000000
0000000000000000000000000000000-2-40000
000000000-101-100-10001-1-1-10-1000100122-8-10
00000000000000100000010010-1017220353964
0000000000000000000000000000000000222
0000000000000000000000000000000000000
-1-10-10-1000-1-4-7-6-4-4-5-5-4-7-3-7-8-8-4-2-3-3-7-10-9-7-3-6-3-14-6-7
0000000000000000000000-1000000000-10000
0000000000000-100100-35871180020000-1-10000
0000000000000-100200-35971280020000-100000
0000000000000000000000000000000000000
00010000000000100000000000000103303400
00000100027764575151321000300150212601264
000101000276647651513210003001501255741764
-------------------------------------
0000000000000000000000000000000000000
-1-1000000002-10-12129-7-62-1241-4-17-112-20-1030-3
-1.19-1.19-0.29-1.12-0.35-1.23-0.710.02-0.08-1.9-5.69-8.42-6.56-4.46-4.53-5.64-5.8-5.33-8.16-3.57-8.38-8.96-9.81-4.9-2.36-4.44-3.47-8.24-11.24-10.34-7.6-3.62-8.22-3.44-14.41-6.71-7.68
0000000000000000000000000000000000000

Thermogenesis Holdings stock margins

The Thermogenesis Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Thermogenesis Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Thermogenesis Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Thermogenesis Holdings's sales revenue. A higher gross margin percentage indicates that the Thermogenesis Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Thermogenesis Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Thermogenesis Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Thermogenesis Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Thermogenesis Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Thermogenesis Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Thermogenesis Holdings Margin History

Thermogenesis Holdings Gross marginThermogenesis Holdings Profit marginThermogenesis Holdings EBIT marginThermogenesis Holdings Profit margin
2029e20.44 %0 %27.26 %
2028e20.44 %43.74 %27.51 %
2027e20.44 %35.73 %22.09 %
2026e20.44 %32.43 %19.97 %
2025e20.44 %24.14 %15.02 %
2024e20.44 %12.01 %7.5 %
202320.44 %-69.6 %-190.31 %
202225.86 %-59.06 %-107.54 %
202137.57 %-77.83 %-122.5 %
202012.94 %-91.38 %-167.86 %
201943.68 %-36.25 %-72.8 %
201822.65 %-108.27 %-410.75 %
201740.19 %-63.59 %-200.28 %
201622.97 %-91.03 %-155.83 %
201529.61 %-92.64 %-92.58 %
201436.84 %-56.54 %-53.97 %
201336.36 %-28.23 %-17.2 %
201233.28 %-28.29 %-26.24 %
201137.78 %-12.14 %-10.98 %
201032.27 %-22.74 %-22.48 %
200928.74 %-44.34 %-43.18 %
200831.75 %-47.24 %-41.82 %
200731.04 %-50.99 %-40.48 %
200636.02 %-57.84 %-50.95 %
200530.35 %-82.71 %-80.75 %
200432.62 %-41.55 %-41.03 %

Thermogenesis Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Thermogenesis Holdings earnings per share therefore indicates how much revenue Thermogenesis Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thermogenesis Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thermogenesis Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thermogenesis Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thermogenesis Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Thermogenesis Holdings Revenue, EBIT and net profit per share

DateThermogenesis Holdings Sales per ShareThermogenesis Holdings EBIT per shareThermogenesis Holdings Earnings per Share
2029e1.91 undefined0 undefined0.52 undefined
2028e1.89 undefined0 undefined0.52 undefined
2027e1.62 undefined0 undefined0.36 undefined
2026e1.58 undefined0 undefined0.32 undefined
2025e1.36 undefined0 undefined0.2 undefined
2024e1.09 undefined0 undefined0.08 undefined
20233.99 undefined-2.78 undefined-7.59 undefined
202219.05 undefined-11.25 undefined-20.49 undefined
202135.73 undefined-27.81 undefined-43.77 undefined
202069.57 undefined-63.57 undefined-116.79 undefined
2019217.5 undefined-78.83 undefined-158.33 undefined
2018241.75 undefined-261.75 undefined-993 undefined
2017726.5 undefined-462 undefined-1,455 undefined
20161,193 undefined-1,086 undefined-1,859 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined

Thermogenesis Holdings business model

ThermoGenesis Holdings Inc. is a company specializing in the development and marketing of innovative medical technologies. It was founded in 1986 under the name Symbiosis Corporation and is headquartered in Rancho Cordova, California. The company has roots in stem cell research and has focused on developing and commercializing stem cell therapies for patients. It works closely with medical institutions and government agencies to ensure its products meet the latest standards and patient needs. ThermoGenesis Holdings is divided into two divisions: ThermoGenesis Corp., which develops and produces medical devices for stem cell therapy, and Cellerant Therapeutics, which focuses on therapies for blood and immune system disorders. ThermoGenesis Corp. offers a range of devices and systems for stem cell therapy, including the AXP system, the CryoSeal system, and the Res-Q-60 system. Cellerant Therapeutics develops therapies, with a focus on gene therapies, to restore the immune system. Thermogenesis Holdings is one of the most popular companies on Eulerpool.com.

Thermogenesis Holdings SWOT Analysis

Strengths

  • Thermogenesis Holdings Inc. possesses a strong portfolio of patented medical technologies in the field of regenerative medicine and cell therapy.
  • The company has a proven track record of successful product development and commercialization, with several FDA-approved therapies in its pipeline.
  • Thermogenesis has a robust and experienced management team with deep expertise in the healthcare industry.

Weaknesses

  • The company heavily relies on research and development, which results in high operating costs and potential delays in product commercialization.
  • Thermogenesis faces strong competition from large pharmaceutical companies and other emerging biotech firms in the regenerative medicine industry.
  • Limited global reach and distribution networks may hinder the company's ability to expand its market presence internationally.

Opportunities

  • The growing prevalence of chronic diseases and the need for advanced regenerative therapies present significant market opportunities for Thermogenesis.
  • Increasing adoption of cell-based therapies and the shift towards personalized medicine create a favorable market environment for the company.
  • Partnerships and collaborations with leading research institutions and healthcare organizations can enhance Thermogenesis' research capabilities and market access.

Threats

  • Stringent regulatory requirements and potential delays in obtaining necessary approvals may affect the company's ability to bring products to market in a timely manner.
  • Technological advancements by competitors and potential intellectual property disputes pose threats to Thermogenesis' market position and product differentiation.
  • Global economic fluctuations and healthcare budget constraints can impact the demand for expensive regenerative therapies and limit market growth.

Thermogenesis Holdings Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Thermogenesis Holdings Revenue by Segment

Segmente202020192018201720162015
Service1.41 M -USD1.68 M -USD1.73 M -USD---
The product representing a significant concentration------

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Thermogenesis Holdings Revenue by Segment

Segmente202020192018201720162015
Device Revenue7.99 M -USD11.22 M -USD----
Other348,000 -USD146,000 -USD----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Thermogenesis Holdings Revenue by Segment

Segmente202020192018201720162015
Device Revenue--7.84 M -USD---
Other--95,000 -USD---

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Thermogenesis Holdings Revenue by Segment

Segmente202020192018201720162015
Device351,000 -USD12.96 M -USD9.47 M -USD14.03 M -USD--
AXP---8.72 M -USD6.93 M -USD6.61 M -USD
BioArchive---3.32 M -USD2.47 M -USD4.24 M -USD
Manual Disposables---1.2 M -USD1.51 M -USD1.81 M -USD
Bone Marrow---745,000 -USD459,000 -USD2.62 M -USD
Other Segments---552,000 -USD566,000 -USD758,000 -USD
Clinical Development-90,000 -USD203,000 -USD492,000 -USD--

Thermogenesis Holdings Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Thermogenesis Holdings Revenue by Segment

DateAll Other CountriesAsia - otherAsia - OtherChinaCHINAEuropeHong KongOther continentsSouth AmericaUnited States
2019573,000 -USD-2.11 M -USD-2.35 M -USD1.23 M -USD---6.79 M -USD
2017864,000 -USD-1.95 M -USD-3.3 M -USD1.74 M -USD---6.68 M -USD
2016712,000 -USD-1.96 M -USD-2.8 M -USD1.34 M -USD---5.12 M -USD
2015282,000 -USD-1.96 M -USD-2.5 M -USD2.15 M -USD--730,000 -USD8.43 M -USD
2014-1.86 M -USD-848,000 -USD-3.07 M -USD2.32 M -USD202,000 -USD771,000 -USD6.91 M -USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Thermogenesis Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Thermogenesis Holdings historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Thermogenesis Holdings shares outstanding

The number of shares was Thermogenesis Holdings in 2023 — This indicates how many shares 2.368 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thermogenesis Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thermogenesis Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thermogenesis Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thermogenesis Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Thermogenesis Holdings stock splits

In Thermogenesis Holdings's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Thermogenesis Holdings.

Thermogenesis Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20240.01 -0.46  (-4,609.8 %)2024 Q1
12/31/2023-0.01 -1.47  (-14,311.76 %)2023 Q4
9/30/2023-0.21 -1.44  (-572.27 %)2023 Q3
6/30/20230.01 -0.91  (-9,021.57 %)2023 Q2
3/31/2023-0.32 -0  (99.05 %)2023 Q1
9/30/2022-1.38 -4.5  (-226.8 %)2022 Q3
12/31/2021-2.75 -9.9  (-259.48 %)2021 Q4
9/30/2021-3.67 -6.75  (-83.82 %)2021 Q3
6/30/2021-8.26 -17.1  (-106.97 %)2021 Q2
3/31/2021-5.97 -9.45  (-58.37 %)2021 Q1
1
2
3

Thermogenesis Holdings shareholders

%
Name
Stocks
Change
Date
28.01438 % Boyalife Investment Inc4,440,2794,113,1583/31/2024
0.00013 % Cauble (Jeffery)2003/31/2024
0.00009 % Osaic Holdings, Inc.14-126/30/2024
0.00001 % CIBC Private Wealth Management106/30/2024
0 % Qube Research & Technologies Ltd0-46/30/2024
0 % Sound Income Strategies, LLC0-312/31/2023
0 % Parallel Advisors, LLC0-16/30/2024
0 % Armistice Capital LLC0-125,0006/30/2023
0 % Allworth Financial, L.P.0-13/31/2024
0 % Morgan Stanley Smith Barney LLC0-276/30/2024
1
2
3
4

Thermogenesis Holdings Executives and Management Board

Dr. Xiaochun Xu

(52)
Thermogenesis Holdings Chairman of the Board, President, Chief Executive Officer (since 2016)
Compensation 699,000

Ms. Haihong Zhu

(58)
Thermogenesis Holdings Chief Operating Officer, Director (since 2022)
Compensation 554,000

Mr. Jeffery Cauble

(50)
Thermogenesis Holdings Chief Financial Officer
Compensation 325,000

Dr. James Xu

(52)
Thermogenesis Holdings Independent Director (since 2016)
Compensation 99,000

Dr. Joseph Thomis

(77)
Thermogenesis Holdings Independent Director
Compensation 56,000
1
2

Thermogenesis Holdings Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
ScinoPharm Taiwan Stock
ScinoPharm Taiwan
SupplierCustomer0,340,930,220,270,720,79
Corning Stock
Corning
SupplierCustomer0,220,570,390,310,52-0,33
Danaher Stock
Danaher
SupplierCustomer-0,280,570,860,850,40-0,64
1

Most common questions regarding Thermogenesis Holdings

What values and corporate philosophy does Thermogenesis Holdings represent?

Thermogenesis Holdings Inc represents values of innovation, excellence, and commitment in the field of regenerative medicine. With a strong corporate philosophy focused on advancing cell and gene therapies, the company aims to revolutionize the treatment of various diseases and conditions. By harnessing cutting-edge technologies, Thermogenesis Holdings Inc is dedicated to providing high-quality solutions that enhance patient outcomes and quality of life. The company's emphasis on research, development, and collaboration with key industry players reflects its commitment to driving progress and improving healthcare worldwide.

In which countries and regions is Thermogenesis Holdings primarily present?

Thermogenesis Holdings Inc is primarily present in the United States.

What significant milestones has the company Thermogenesis Holdings achieved?

Thermogenesis Holdings Inc has achieved several significant milestones in its history. The company has successfully developed and brought to market innovative medical devices and technologies, establishing itself as a leader in the field of regenerative medicine. Thermogenesis Holdings Inc has achieved notable advancements in the collection and processing of stem cells, revolutionizing the industry. Additionally, the company has expanded its product portfolio and entered into strategic partnerships, further solidifying its position in the market. Thermogenesis Holdings Inc continues to drive innovation and make significant contributions to the field of regenerative medicine, positioning itself for continued growth and success.

What is the history and background of the company Thermogenesis Holdings?

Thermogenesis Holdings Inc, an American company, has a rich history and background in the medical technology industry. Established in 1986, the company focuses on developing and commercializing innovative cell and tissue-based products. With a strong emphasis on regenerative medicine, Thermogenesis Holdings Inc has gained expertise in designing and manufacturing advanced systems for the processing and storage of cellular therapies. The company has received multiple FDA approvals and has collaborated with renowned medical institutions worldwide. Thermogenesis Holdings Inc continues to revolutionize the field of regenerative medicine, striving to improve patient outcomes through its cutting-edge solutions.

Who are the main competitors of Thermogenesis Holdings in the market?

The main competitors of Thermogenesis Holdings Inc in the market are CryoPort, Inc. and Cesca Therapeutics Inc.

In which industries is Thermogenesis Holdings primarily active?

Thermogenesis Holdings Inc is primarily active in the healthcare industry.

What is the business model of Thermogenesis Holdings?

The business model of Thermogenesis Holdings Inc. revolves around the development and commercialization of innovative cell and gene therapy technologies. With a focus on regenerative medicine and immunotherapy, Thermogenesis Holdings Inc. aims to provide advanced solutions for various medical conditions. The company utilizes its proprietary platforms and expertise to enable the collection, processing, storage, and administration of cell-based therapies. By collaborating with key industry partners and utilizing cutting-edge technologies, Thermogenesis Holdings Inc. strives to revolutionize the field of regenerative medicine and contribute to patient care and well-being.

What is the P/E ratio of Thermogenesis Holdings 2024?

The Thermogenesis Holdings P/E ratio is 0.

What is the P/S ratio of Thermogenesis Holdings 2024?

The Thermogenesis Holdings P/S ratio is 0.

What is the Quality Investing of Thermogenesis Holdings?

The Quality Investing for Thermogenesis Holdings is 5/10.

What is the revenue of Thermogenesis Holdings 2024?

The expected Thermogenesis Holdings revenue is 17.24 M USD.

How high is the profit of Thermogenesis Holdings 2024?

The expected Thermogenesis Holdings profit is 1.29 M USD.

What is the business model of Thermogenesis Holdings

Thermogenesis Holdings Inc. is a company that has been operating in the health and biotechnology industry since 1986. The company's business model consists of three business areas focusing on stem cell therapy, diagnostics, and customer service. In the area of stem cell therapy, Thermogenesis Holdings Inc. offers products and services for stem cell collection, processing, and storage. The company's innovative solutions allow for the extraction, isolation, and freezing of stem cells from blood, umbilical cord, and bone marrow. These stem cells can be used in various diseases to promote healing and alleviate symptoms. In the field of diagnostics, Thermogenesis Holdings Inc. offers clinical diagnostic instruments for blood processing, such as the AXP® AutoXpress® system. These systems allow medical professionals to isolate stem cells and further develop them in clinical research. Additionally, the company also provides cell culture systems and devices for cell analysis and characterization, such as the FreezerPro® system. In addition to these two main areas, Thermogenesis Holdings Inc. also provides comprehensive customer service. The company offers a 24/7 hotline, technical support, as well as customized training and education for its customers. The main product of Thermogenesis Holdings Inc. is the CryoSeal® FS system for processing tissues and organs intended for transplantation. It is used in combination with the cell processing technology MXP®, allowing for fast and effective processing of various biological materials. From tissues to cells to organs, Thermogenesis Holdings Inc. offers a wide range of solutions. The company also operates in various other countries and has branches in Germany, France, and Finland. Along with its subsidiaries, the company serves customers worldwide. Thermogenesis Holdings Inc. is a company with a long tradition in biotechnological research and development. With its innovative products and solutions, the company has established a leading position in the industry. With a strong presence in the international market and a comprehensive customer service strategy, Thermogenesis Holdings Inc. has made a name for itself.

What is the Thermogenesis Holdings dividend?

Thermogenesis Holdings pays a dividend of 0 USD distributed over payouts per year.

How often does Thermogenesis Holdings pay dividends?

The dividend cannot currently be calculated for Thermogenesis Holdings or the company does not pay out a dividend.

What is the Thermogenesis Holdings ISIN?

The ISIN of Thermogenesis Holdings is US88362L1008.

What is the Thermogenesis Holdings WKN?

The WKN of Thermogenesis Holdings is A2PUSP.

What is the Thermogenesis Holdings ticker?

The ticker of Thermogenesis Holdings is THMO.

How much dividend does Thermogenesis Holdings pay?

Over the past 12 months, Thermogenesis Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Thermogenesis Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Thermogenesis Holdings?

The current dividend yield of Thermogenesis Holdings is .

When does Thermogenesis Holdings pay dividends?

Thermogenesis Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Thermogenesis Holdings?

Thermogenesis Holdings paid dividends every year for the past 0 years.

What is the dividend of Thermogenesis Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Thermogenesis Holdings located?

Thermogenesis Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Thermogenesis Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Thermogenesis Holdings from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Thermogenesis Holdings pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Thermogenesis Holdings in the year 2023?

In the year 2023, Thermogenesis Holdings distributed 0 USD as dividends.

In which currency does Thermogenesis Holdings pay out the dividend?

The dividends of Thermogenesis Holdings are distributed in USD.

All fundamentals about Thermogenesis Holdings

Our stock analysis for Thermogenesis Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Thermogenesis Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.